Covered recipient · General Payments record
MU K HONG
Allopathic & Osteopathic Physicians Internal Medicine Gastroenterology
General Payments · PY2018–2024
$3,005.67
- Reported across 150 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $400.95 | 23 |
| Education | $14.00 | 1 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $137.88 | 12 |
| Janssen Biotech, Inc. | $71.59 | 3 |
| Lilly USA, LLC | $61.94 | 2 |
| Takeda Pharmaceuticals U.S.A., Inc. | $53.93 | 3 |
| PFIZER INC. | $31.45 | 1 |
| Ardelyx, Inc. | $22.40 | 1 |
| Gilead Sciences, Inc. | $21.76 | 1 |
| Celltrion USA Inc. | $14.00 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (24)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201820192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $1.06 | 01/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103935891 | CMS |
| ABBVIE INC. | $23.01 | 01/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103935893 | CMS |
| ABBVIE INC. | $20.30 | 05/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103935895 | CMS |
| ABBVIE INC. | $1.08 | 06/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103935897 | CMS |
| ABBVIE INC. | $2.16 | 06/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103935899 | CMS |
| ABBVIE INC. | $23.44 | 07/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103935901 | CMS |
| ABBVIE INC. | $0.71 | 07/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103935903 | CMS |
| ABBVIE INC. | $21.79 | 07/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103935905 | CMS |
| ABBVIE INC. | $21.00 | 08/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103935907 | CMS |
| ABBVIE INC. | $1.52 | 08/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103935909 | CMS |
| ABBVIE INC. | $19.30 | 08/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103935911 | CMS |
| ABBVIE INC. | $2.51 | 08/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103935913 | CMS |
| Ardelyx, Inc. | $22.40 | 08/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146685290 | CMS |
| Celltrion USA Inc. | $14.00 | 08/06/2024 | Education | Undisputed | 01/23/2026 | 1075852577 | CMS |
| Gilead Sciences, Inc. | $21.76 | 04/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133776991 | CMS |
| Janssen Biotech, Inc. | $26.12 | 02/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078790306 | CMS |
| Janssen Biotech, Inc. | $18.26 | 08/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078790430 | CMS |
| Janssen Biotech, Inc. | $27.21 | 10/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078790426 | CMS |
| Lilly USA, LLC | $33.74 | 04/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135224925 | CMS |
| Lilly USA, LLC | $28.20 | 06/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135208605 | CMS |
| PFIZER INC. | $31.45 | 07/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131767002 | CMS |
| Takeda Pharmaceuticals U.S.A., Inc. | $19.31 | 03/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137578828 | CMS |
| Takeda Pharmaceuticals U.S.A., Inc. | $17.57 | 10/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137578832 | CMS |
| Takeda Pharmaceuticals U.S.A., Inc. | $17.05 | 11/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137578835 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.